This study aimed to develop a risk-prediction model for second primary skin cancer (SPSC) survivors. We identified the clinical characteristics of SPSC and created awareness for physicians screening high-risk patients among skin cancer survivors. Using data from the 1248 skin cancer survivors extracted from five cancer registries, we benchmarked a random forest algorithm against MLP, C4.5, AdaBoost, and bagging algorithms for several metrics. Additionally, in this study, we leveraged the synthetic minority over-sampling technique (SMOTE) for the issue of the imbalanced dataset, cost-sensitive learning for risk assessment, and SHAP for the analysis of feature importance. The proposed random forest outperformed the other models, with an accur...
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
We investigated the predictors of the risk of developing a second primary cancer after breast cancer...
BACKGROUND: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
Basal cell and squamous cell carcinomas of the skin are the commonest cancers in humans, yet no vali...
Basal cell and squamous cell carcinomas of the skin are the commonest cancers in humans, yet no vali...
International audienceBackgroundTo develop a prediction model to quantify the cumulative risk of Sec...
Importance: Identifying individuals at high risk of melanoma can optimize primary and secondary prev...
Cancer-free patients diagnosed with a first primary non-melanoma skin cancer (NMSC) offer an opportu...
IMPORTANCE Identifying individuals at high risk of melanoma can optimize primary and secondary preve...
A third of basal cell carcinoma (BCC) patients will develop subsequent BCCs. We aimed to develop a s...
Skin cancer is the most common malignancy in the world leading to significant morbidity, mortality, ...
Background: Previous studies suggest a positive association between history of non-melanoma skin can...
Background: Most literature on second primary cancers (SPCs) focuses on possible factors, which may ...
Background: Patients with squamous cell skin cancer (SCC) have an excellent prognosis but second pri...
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
We investigated the predictors of the risk of developing a second primary cancer after breast cancer...
BACKGROUND: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
Basal cell and squamous cell carcinomas of the skin are the commonest cancers in humans, yet no vali...
Basal cell and squamous cell carcinomas of the skin are the commonest cancers in humans, yet no vali...
International audienceBackgroundTo develop a prediction model to quantify the cumulative risk of Sec...
Importance: Identifying individuals at high risk of melanoma can optimize primary and secondary prev...
Cancer-free patients diagnosed with a first primary non-melanoma skin cancer (NMSC) offer an opportu...
IMPORTANCE Identifying individuals at high risk of melanoma can optimize primary and secondary preve...
A third of basal cell carcinoma (BCC) patients will develop subsequent BCCs. We aimed to develop a s...
Skin cancer is the most common malignancy in the world leading to significant morbidity, mortality, ...
Background: Previous studies suggest a positive association between history of non-melanoma skin can...
Background: Most literature on second primary cancers (SPCs) focuses on possible factors, which may ...
Background: Patients with squamous cell skin cancer (SCC) have an excellent prognosis but second pri...
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...
We investigated the predictors of the risk of developing a second primary cancer after breast cancer...
BACKGROUND: Conflicting evidence exists about whether people with a history of nonmelanoma skin canc...